Trenonacog alfa

N/A

Report date: 2024/03/28 17:28:44

Base Information

Drug NameTrenonacog alfa
Drug Alias NameRecombinant factor IX (Emergent BioSolutions)曲诺凝血素α/重组凝血因子IX曲凝血素-9α/重组凝血因子IXtrenonacog alfatrenonacogum alfa +[11] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsHemophilia B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2015/05/14
Country/TerritoryUnited StatesUkrainePoland +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesInspiration Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedexus Pharmaceuticals IncMedexus Pharma Inc
Inactive CompaniesCangene Corp
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeB02BD04
Related LinksKEGG